Answers are grounded in this paper and cite their sources.
Spatial transcriptomics measures the expression of hundreds to thousands of genes in each cell together with the cell's position in the tissue. Here we use spatial correlation functions, which describe how the correlation of gene expression between cells decays with distance, to quantify how the spatial organization of gene expression changes in disease. From the correlation function of each gene, or of each pair of genes, we extract two numbers: a susceptibility, which measures how strongly gene expression is correlated between nearby cells, and a correlation length, the distance over which this correlation extends. Both are in physical units and can be compared directly between samples and conditions. We apply the approach to healthy and fibrotic mouse liver using newly generated data, and to healthy and fibrotic human liver using published data. Correlations between gene pairs identify genes of the same hepatocyte zone, and assign a zone to 1,266 genes that are not known zonation markers. The two fibrotic conditions differ: CCl 4 injection in mice produces a moderate reorganization in which some genes lose spatial correlation and others gain it, while in human fibrosis almost every measured gene loses it. Changes in spatial correlation are only weakly related to changes in expression level. For instance Cyp2c29 and Pon1 partially lose their spatial correlation in treated mice, although their average expression does not consistently fall. Spatial correlation functions therefore detect changes in tissue organization that measurements of expression level alone miss.
No takes yet. Share an insight, caveat, or question.
Ginne et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: